Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis
Tong, Xiaofei, et al. Hepatology International (2024): 1-15.
Categories: Publications
Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessment
Kendall, Timothy J., Chng, Elaine, et al. Liver International (2024).
Second harmonic generation digital pathology with artificial intelligence: breakthroughs in studying fibrosis dynamics and treatment response
Nikolai V Naoumov & Elaine Chng. Future Medicine AI (2024).
AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: An exploratory study
Yuan, Hai‐Yang, et al. Liver International (2024).
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
Chen, S., Zhou, J., Wu, X. et al. Hepatol Int (2024). https://doi.org/10.1007/s12072-024-10643-z
Potential of Using qFibrosis Analysis to Predict Recurrent and Survival Outcome of Patients with Hepatocellular Carcinoma after Hepatic Resection
Hsiao, Chih-Yang, et al. Oncology 1-11 (2024)
Leukotriene B4 receptor 1 (BLT1) does not mediate disease progression in a mouse model of liver fibrosis
Coyne, Erin., et al. Biochem J; 481 (3): 177–190.
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
Xie, Li, et al. Clinical and Molecular Hepatology 30.2 (2024): 206.
Digital pathology and artificial intelligence in non-alcoholic steatohepatitis: current status and future directions
Ratziu, Vlad, et al. Journal of Hepatology. October 23, 2023 DOI:https://doi.org/10.1016/j.jhep.2023.10.015
Persistent steatosis correlates with decreased fibrosis regression during anti-HBV treatment in patients with chronic HBV infection
Zhang, Mengyang and Chen, Shuyan, et al. Journal of Medical Virology 95.10 (2023): e29156.